Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India · Delayed Price · Currency is INR 67.66
+1.46 (2.21%)
At close: Aug 11, 2025
BOM:524412 Revenue
In the fiscal year ending March 31, 2025, Aarey Drugs & Pharmaceuticals had annual revenue of 4.74B INR with 19.80% growth. Aarey Drugs & Pharmaceuticals had revenue of 1.08B in the quarter ending March 31, 2025, a decrease of -48.61%.
Revenue
4.74B
Revenue Growth
+19.80%
P/S Ratio
0.39
Revenue / Employee
35.90M
Employees
132
Market Cap
1.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.74B | 783.25M | 19.80% |
| Mar 31, 2024 | 3.96B | -233.38M | -5.57% |
| Mar 31, 2023 | 4.19B | -739.78M | -15.01% |
| Mar 31, 2022 | 4.93B | 1.42B | 40.27% |
| Mar 31, 2021 | 3.51B | 505.20M | 16.79% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |